Program’s focus: Skin cancer Times Leader
Skin cancer is now the world’s most common cancer and is occurring at epidemic rates. More than a million new cases of skin cancer are diagnosed in the United States every year.
70-year-old cancer survivor keeps on running Glenwood Springs Post Independent
For 30 years, Richard Sutton's life has revolved around running. When he was 40 years old, he weighed in at 250 pounds, and with a history of heart problems in his family, Sutton started running. Since then, nothing seems to be able to slow him down.
Scientists Find 'Chemo Brain' No Figment Of The Imagination Science Daily
For the first time, UCLA researchers have found that chemotherapy causes measurable changes to the brain's metabolism and blood flow that can linger at least 10 years after treatment. The new imaging study may help explain "chemo brain" -- the mental confusion, memory loss and inability to concentrate that plague many chemotherapy patients.
Curis gets $3 million from Genentech bizjournals.com via Yahoo! Finance
Drug developer Curis Inc. will receive a $3 million milestone payment now that partner, Genentech Inc., has made progress on a new drug.
Skin Cancer Screening Tour Continues Its Life-Saving Trip PR Newswire via Yahoo! Finance
Bradley Pharmaceuticals, Inc. announced today that to date, The Skin Cancer Screening Tour, sponsored jointly by the Doak Dermatologics subsidiary of Bradley Pharmaceuticals and The Skin Cancer Foundation, has provided free screenings for more than 5000 individuals, and raised considerable public awareness of the importance of regular visits to a dermatologist for early detection of skin cancer.
Curis, Inc. Announces Genentech Filing of Investigational New Drug Application for Systemic Administration of a FinanzNachrichten
Curis, ( Nachrichten ) Inc., (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, announced today that Genentech, ( Nachrichten ) a collaborator, has filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) to initiate Phase I clinical testing of a systemically administered small
Curis, Inc. Announces Genentech Filing of Investigational New Drug Application for Systemic Administration of a Business Wire via Yahoo! Finance
CAMBRIDGE, Mass.----Curis, Inc., , a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, announced today that Genentech, a collaborator, has filed an Investigational New Drug application with the Food and Drug Administration to initiate Phase I clinical testing of a systemically administered small molecule Hedgehog antagonist for the
Walking for a future Town Online
My youngest daughter, Jennifer, walked 26.2 miles on Sunday. It took her a little less than eight hours. She walked for her uncle, who died of cancer two years ago. She walked for her grandmother, who died of cancer eight years ago. She walked for her father-in-law, who died of cancer 13 years ago.
PharmaMar Reports New Data on Kahalalide-F and AplidinR at ESMO Congress campus med
Istanbul, Turkey (ots/PRNewswire) - PharmaMar, the biopharmaceutical company specialising in cancer therapy, announces today that it is to present new data from two of its clinical compounds, Kahalalide F and Aplidin(R), at the 31st European Society for Medical Oncology Congress (ESMO) being held in Istanbul, Turkey from 29 September to 3 October 2006.
PharmaMar Reports New Data on Kahalalide-F and AplidinR at ESMO Congress Presseportal
Istanbul, Turkey (ots/PRNewswire) - PharmaMar, the biopharmaceutical company specialising in cancer therapy, announces today that it is to present new data from two of its clinical compounds, Kahalalide F and Aplidin(R), at the 31st European

AAD - Basal Cell Carcinoma
Basal cell carcinoma is the most common form of cancer worldwide. In the vast majority of cases, it is thought to be caused by exposure to the harmful
MedlinePlus Medical Encyclopedia: Basal cell carcinoma
Basal cell carcinoma is a slow-growing skin tumor involving cancerous changes in basal Basal cell carcinoma is the most common form of cancer in the US.
Basal cell carcinoma - Wikipedia, the free encyclopedia
Basal cell carcinoma (BCC) is the most common skin cancer. Histopathology: Basal cell carcinoma is a malignant epithelial tumor arising only in skin,
eMedicine - Basal Cell Carcinoma : Article by Robert S Bader, MD
Basal Cell Carcinoma - Basal cell carcinoma (BCC) is the most common cutaneous malignancy in humans. These tumors typically appear on sun-exposed skin,
Basal Cell Carcinoma
American Osteopathic College of Dermatology skin disease database: In the United States skin cancer is the most common malignant tumor.Basal Cell Cancer


Basal cell carcinoma - Wikipedia, the free encyclopedia
Basal cell carcinoma (BCC) is the most common skin cancer. Histopathology: Basal cell carcinoma is a malignant epithelial tumor arising only in skin,
eMedicine - Basal Cell Carcinoma : Article by Robert S Bader, MD
Basal Cell Carcinoma - Basal cell carcinoma (BCC) is the most common cutaneous malignancy in humans. These tumors typically appear on sun-exposed skin,
Basal Cell Carcinoma
American Osteopathic College of Dermatology skin disease database: In the United States skin cancer is the most common malignant tumor.Basal Cell Cancer
Basal cell carcinoma, BCC. DermNet NZ
Authoritative facts about the skin from the New Zealand Dermatological Society.
Basal cell carcinoma -- Wong et al. 327 (7418): 794 -- BMJ
Basal cell carcinoma is the most common malignancy in white people.1 Its Although mortality is low as basal cell carcinoma rarely metastasises,
Basal Cell Carcinoma - Information About Basal Cell Carcinoma
Basal cell carcinoma is the most common type of skin cancer. Find out more about what basal cell carcinoma looks like and who is at risk for getting this
basal cell carcinoma
Basal cell carcinoma may occur on skin that is not sun exposed, although involvement of Here is another example of sclerosing basal cell carcinoma.
squamous cell carcinoma
A biopsy of the base of one of these horny tumors revealed squamous cell carcinoma. He declined treatment saying that it had been there for a long time and